
Shandong Bailong Chuangyuan Bio-Tech Co Ltd
SSE:605016

Shandong Bailong Chuangyuan Bio-Tech Co Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
14.5347
27.5899
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Shandong Bailong Chuangyuan Bio-Tech Co Ltd hold over its rivals?
What risks and challenges
does Shandong Bailong Chuangyuan Bio-Tech Co Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide an overview of the primary business activities
of Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
What unique competitive advantages
does Shandong Bailong Chuangyuan Bio-Tech Co Ltd hold over its rivals?
What risks and challenges
does Shandong Bailong Chuangyuan Bio-Tech Co Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide P/S
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide P/E
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide P/OCF
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide P/FCFE
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide P/B
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide EV/S
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide EV/GP
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide EV/EBITDA
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide EV/EBIT
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide EV/OCF
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide EV/FCFF
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide EV/IC
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Show me price targets
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd made by professional analysts.
What are the Revenue projections
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd?
How accurate were the past Revenue estimates
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd?
What are the Net Income projections
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd?
How accurate were the past Net Income estimates
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd?
What are the EPS projections
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd?
How accurate were the past EPS estimates
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd?
What are the EBIT projections
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd?
How accurate were the past EBIT estimates
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd?
Compare the revenue forecasts
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Shandong Bailong Chuangyuan Bio-Tech Co Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Shandong Bailong Chuangyuan Bio-Tech Co Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of Shandong Bailong Chuangyuan Bio-Tech Co Ltd compared to its peers.
Compare the P/E ratios
of Shandong Bailong Chuangyuan Bio-Tech Co Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing Shandong Bailong Chuangyuan Bio-Tech Co Ltd with its peers.
Analyze the financial leverage
of Shandong Bailong Chuangyuan Bio-Tech Co Ltd compared to its main competitors.
Show all profitability ratios
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide ROE
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide ROA
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide ROIC
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide ROCE
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide Gross Margin
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide Operating Margin
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide Net Margin
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide FCF Margin
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Show all solvency ratios
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide D/E Ratio
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide D/A Ratio
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide Interest Coverage Ratio
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide Altman Z-Score Ratio
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide Quick Ratio
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide Current Ratio
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Provide Cash Ratio
for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
What is the historical Revenue growth
over the last 5 years for Shandong Bailong Chuangyuan Bio-Tech Co Ltd?
What is the historical Net Income growth
over the last 5 years for Shandong Bailong Chuangyuan Bio-Tech Co Ltd?
What is the current Free Cash Flow
of Shandong Bailong Chuangyuan Bio-Tech Co Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for Shandong Bailong Chuangyuan Bio-Tech Co Ltd.
Shandong Bailong Chuangyuan Bio-Tech Co Ltd's latest stock split occurred on Jun 6, 2024
The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.
Before the split, Shandong Bailong Chuangyuan Bio-Tech Co Ltd traded at 29.8301 per share. Afterward, the share price was about 22.3112.
The adjusted shares began trading on Jun 6, 2024. This was Shandong Bailong Chuangyuan Bio-Tech Co Ltd's 3rd stock split, following the previous one in Jun 1, 2023.
Global
Stock Splits Monitor
Shandong Bailong Chuangyuan Bio-Tech Co Ltd
Glance View
Shandong Bailong Chuangyuan Bio-Tech Co Ltd is a CN-based company operating in Food Products industry. The company is headquartered in Dezhou, Shandong and currently employs 607 full-time employees. The company went IPO on 2021-04-21. Shandong Bailong Chuangyuan Bio-Tech Co Ltd is a China-based company mainly engaged in food additives. The firm's main businesses include prebiotic series products, mainly including fructooligosaccharides, isomalt oligosaccharides, galacto-oligosaccharides, xylo-oligosaccharides; dietary fiber series products, mainly including resistant dextrin and polydextrose; other starch sugar (alcohol) products, mainly including maltitol, fructose syrup, and maltose syrup; and healthy sweetener products, mainly for the research and development, production and sales of allulose. The firm's main products are widely used in food, dairy products, infant milk powder, functional beverages, health care products, medicine, animal nutrition and feed industries.
